Market revenue in 2023 | USD 65.2 million |
Market revenue in 2030 | USD 147.9 million |
Growth rate | 12.4% (CAGR from 2023 to 2030) |
Largest segment | Scaffold based |
Fastest growing segment | Scaffold Free |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, PROMOCELL, Lonza Group Ltd, Corning Inc, Avantor Inc, Tecan Group AG, ReproCELL, CN Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d cell culture market will help companies and investors design strategic landscapes.
Scaffold based was the largest segment with a revenue share of 48.93% in 2023. Horizon Databook has segmented the Japan 3d cell culture market based on scaffold based, scaffold free, bioreactors, microfluidics, bioprinting covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is projected to witness surging growth in the coming years owing to developing market and increasing participation of the government in this region. Furthermore, release of new products in the 3D cell culture market in Japan is anticipated to enhance segment growth.
For instance, recently, companies such as Pluristem Therapeutics, provide 3D culturing methods, allowing production of cell therapies from fat cells received patent for this technology, thus propelling segment growth. Moreover, cell-based regenerative medicine is currently being focused upon by the Japanese government indicating further developments in 3D cell culture technology, which is expected to result in growth of this segment over the forecast period.
Technological advancements pertaining to stem cell research in the country coupled with well-defined regulatory policies for research on human embryonic stem cells is anticipated to support growth of the Japanese market. Moreover, investments by North American and European players within the 3D cell culture market of the country is expected to drive progress in this vertical.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan 3d cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Japan 3d cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account